Xpert BCR-ABL Ultra
Automated quantitative molecular test for BCR::ABL1 major-breakpoint transcripts used for chronic myeloid leukemia monitoring.
- Developer
- Cepheid
- Intended use
- Monitoring
- Cancer scope
- Chronic myeloid leukemia
- Specimen
- Peripheral whole blood
- Molecular modality
- RNA
- Current version
- Current Xpert BCR-ABL Ultra IVD configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.